This inventor holds 2 USPTO granted patents and 2 published patent applications. Top assignee: Protalix Ltd.. Active years: 2026.
Company Filing History:
Years Active: 2026
Title: Shelly Rozen: Innovator in Uric Acid Treatment
Introduction
Shelly Rozen is a prominent inventor based in Yuvalim, Israel. She has made significant contributions to the field of medical treatments, particularly focusing on diseases associated with elevated uric acid levels. With a total of 2 patents to her name, her work is paving the way for innovative solutions in healthcare.
Latest Patents
Among her latest patents are "Methods of Treating Diseases Associated with Elevated Uric Acid" and "Modified Uricase and Uses Thereof." These patents reflect her commitment to addressing critical health issues and improving patient outcomes through advanced medical technologies.
Career Highlights
Shelly Rozen is currently associated with Protalix Ltd., a company known for its pioneering work in biopharmaceuticals. Her role at Protalix Ltd. allows her to collaborate with other experts in the field and contribute to groundbreaking research and development.
Collaborations
Throughout her career, Shelly has worked alongside talented individuals such as Gil Arvatz and Yakir Nataf. These collaborations have enhanced her research and expanded the impact of her inventions.
Conclusion
Shelly Rozen's innovative work in treating diseases related to elevated uric acid showcases her dedication to advancing medical science. Her contributions are vital in the ongoing quest for effective treatments and improved health outcomes.